InvestorsHub Logo
Followers 0
Posts 960
Boards Moderated 0
Alias Born 04/05/2009

Re: None

Saturday, 11/14/2015 6:59:27 AM

Saturday, November 14, 2015 6:59:27 AM

Post# of 35791
... gross profit margins between 250% to over 2000% ...

(And!! Sannabis has reached breakeven in the month of September!!)

http://www.wallstreet-online.de/nachricht/8071749-colombia-health-minister-announces-decree-to-legalize-commercialization-of-medical-marijuana-products

Colombia Health Minister Announces Decree to Legalize Commercialization of Medical Marijuana Products
Marketwired | 29.10.2015

MIAMI, FL and CALI, COLOMBIA--(Marketwired - Oct 29, 2015) - New Colombia Resources, Inc. (OTC PINK: NEWC) ("New Colombia" or the "Company"), a U.S. company with specialty metallurgical coal, medical marijuana, and hemp assets, is pleased to announce the decision of Colombia's Health Minister to allow for the manufacture and sale of medical marijuana products.

Health Minister Alejandro Gaviria stated he is working on a decree to allow for the commercialization of medical cannabis products that would legalize the elaboration and sale of phytotherapeutic products or herbal medicines that contain cannabis. "The decree is about creating the possibility to form an Agro business that sells legal marijuana products, for example ointments, creams and oils..." stated the Minister. He went on to comment that some of these products are already legally being sold.

New Colombia Resource's subsidiary, Sannabis SAS, has been legally producing medicines on the TOEZ Indian reservation for two years. This site in Norte del Cauca has ideal growing conditions and is home to some of the most sought after strains in the World. Sannabis is securing their market share for medical marijuana products by working directly with indigenous families, insuring their ability to organically produce clones of Sannabis strains, and guaranteeing the purchase of their crop every quarter. Sannabis then manufactures and packages the products on the reservation. A state of the art laboratory built to INVIMA standards is nearing completion. This lab will process hundreds of pounds of medical cannabis per day. Sannabis currently operates at gross profit margins between 250% to over 2000% on their products. These profits are reinvested in securing high quality standards for their medicines and new distribution channels.

"We have been promoting and investing in Colombia's legal medical marijuana products market for some time and believe we will grow significantly once our state of the art laboratory is completed next month. Colombia's administration should be recognized on their forward thinking and courage to right a wrong that has plagued this country for too long," said John Campo, President of New Colombia Resources. "We aim to make 'Made in Colombia' medical marijuana and hemp products the gold standard," further stated Mr. Campo.

In addition to medical marijuana products, New Colombia intends to plant hundreds of hectares of industrial hemp to cost effectively produce bio-diesel with extractors near production zones.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.